Bausch Health Companies Inc. (BMY.US) Chief Medical Officer unexpectedly resigns.

According to the Zhutong Financial APP, the chief medical officer of Bristol-Myers Squibb (BMY.US) has resigned after six years with the company, this news comes as a surprise because the pharmaceutical company is eager to find the next best-selling product to reverse its declining performance. Bristol-Myers Squibb released a statement on Friday stating that Samit Hirawat, who is responsible for the company's new drug development, will leave on August 1 and continue to serve as a consultant for the company until November.